Optic IconOptic Logo
|
SearchCollectionsBenchmarks

Suvemcitug

1 abstract

Abstract
A phase III randomized, double-blinded, placebo-controlled study of suvemcitug combined with chemotherapy for platinum-resistant ovarian cancer (SCORES).
Org: State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, China, Shanghai Xianxiang Medical Technology Co., Ltd, Shanghai, China,